查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
組學研究服務市場規模份額趨勢分析報告:按服務(基因組學,蛋白質組學),按業務(醫院),按服務頻率(單次),按產品,按最終用途,按地區,分部預測,2023-2030年
市場調查報告書
商品編碼
1178600

組學研究服務市場規模份額趨勢分析報告:按服務(基因組學,蛋白質組學),按業務(醫院),按服務頻率(單次),按產品,按最終用途,按地區,分部預測,2023-2030年

Omics Lab Services Market Size, Share & Trends Analysis Report By Services (Genomics, Proteomics), Business (Hospitals), Frequency Of Service (One-off), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

組學研究服務的市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球組學研究服務市場規模預計將達到 1940.4 億美元，預測期內的複合年增長率為 13.72%。市場的發展是由於基因組數據越來越多地整合到臨床工作流程中，以及越來越多地採用直接面向消費者的組學。此外，對早期疾病診斷測試和技術進步的需求增加以及政府資金的增加進一步推動了整個市場的增長。

人們越來越意識到組學在人類疾病管理和其他非傳統應用中的潛力，這推動了組學數據的採用。因此，尋求利用可用遺傳信息引入產品和技術的公司之間的競爭日益激烈，使他們能夠利用市場上充足的增長途徑。先進的實驗室分析還將支持精準醫療和個性化醫療的發展，並產生超越一般患者護理的影響。腫瘤學領域已經取得了長足的進步，組學和單細胞顯微技術的發展極大地促進了未來以患者為中心的方法的發展。

此外，腫瘤學領域從組學研究中獲益最多，NGS 臨床檢測的一項新興應用是血漿中循環腫瘤 DNA (ctDNA) 的定量。可以使用多種 NGS 技術，例如通過深度測序進行癌症個性化分析。高通量 RNA 測序的發展凸顯了轉錄組學在生物學和臨床研究中的重要性。通過 NGS 技術和微陣列進行的 RNA 測序是執行轉錄組學的兩種方法。蛋白質組學和代謝組學是兩個以 NMR 和 MS 技術的改進為特徵的領域。

此外，市場上的主要參與者正專注於將組學技術納入早期診斷。例如，2021年5月，Burning Rock Biotech Limited啟動了中國首個泛癌多組學早期檢測研究PRESCIENT。2022年3月，PrognomiQ投資4600萬美元推進用於早期癌症檢測的多組學開發。2022 年 9 月，Bertis 開始了用於卵巢癌診斷的新型生物標誌物的蛋白質組學研究。此外，2022 年 7 月，Mission Bio 宣布了 Tapestri 平台，用於血液惡性腫瘤中基於單細胞多組學的 MRD 檢測。這些在組學領域開發早期診斷工具的舉措和研究進一步推動了整個組學研究服務市場的增長。

組學研究服務市場報告亮點

表觀遺傳部分預計在預測期內增長最快，這可歸因於表觀遺傳分析提供的未來潛力

診斷實驗室部分將在 2021 年佔據最大的市場份額，原因是測試的增加以及執行診斷測試的更廣泛資源的可用性。

硬件設備行業預計將在 2021 年主導組學研究服務市場，並在預測期內呈現最快的增長速度。這是由於通過硬件儀器的發展，基因組學和轉錄組學技術的快速進步。

由於基因檢測的高準確性、敏感性和特異性，北美越來越多地採用基因檢測，因此北美佔據最大的市場份額

目錄

第一章 調查方法和範圍

  • 市場細分
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • 次要信息
    • 初步調查
    • 初步調查詳情
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法一：商品流動方法
      • 方法 2：使用自下而上的方法逐個國家/地區進行市場估算
  • 全球市場：複合年增長率計算
  • 調查假設
  • 二級信息列表
  • 主要信息列表
  • 目的
  • 縮略語表

第二章執行摘要

  • 市場快照
  • 段快照
  • 競爭格局的快照

3. 組學研究服務市場變量、趨勢和範圍

  • 組學研究服務市場線展望
    • 母公司市場展望
      • 診斷市場
      • 生物技術市場
  • 繪製滲透率和增長前景
  • 市場驅動力分析
    • 將基因組學數據整合到臨床工作流程中的進展
      • 更有針對性和個性化的醫療保健
      • 不斷發展的新生兒基因篩查項目
      • 無創癌症篩查的進展
    • 越來越多地採用 D2C 組學
    • 對早期疾病診斷測試的需求不斷增長
    • 技術進步
    • 增加服務的需求/採用
    • 各類企業參與度增加
    • 增加政府資助
  • 市場約束因素分析
    • 缺乏熟練的專業人員
    • 組學技術實施緩慢
  • SWOT 分析，按因素（政治和法律、經濟、技術）
  • 波特五力分析
  • 監管框架

第四章組學研究服務市場-細分分析，按服務分類，2018-2030 年（百萬美元）

  • 定義和範圍
  • 組學研究服務市場：服務波動分析
    • 基因組學
    • 蛋白質組學
    • 轉錄組學
      • 轉錄組體內分析 (Tiva)
      • 免疫組化
      • 基於顯微鏡的 Rns 成像技術
    • 代謝組學
    • 表觀遺傳學
      • 2018-2030 年表觀遺傳學市場估計和預測（百萬美元）

第 5 章組學研究服務市場-細分分析，按業務劃分，2018-2030 年（百萬美元）

  • 組學研究服務市場：業務波動分析
    • 醫院
    • 調查
    • 診斷實驗室

6. 組學研究服務市場——細分分析，按服務頻率，2018-2030 年（百萬美元）

  • 定義和範圍
  • 組學研究服務市場：服務變化頻率分析
    • 一次性的
    • 重複
    • 繼續

第 7 章組學研究服務市場-細分分析，按產品，2018-2030 年（百萬美元）

  • 定義和範圍
  • 組學研究服務市場：產品變異分析
    • 硬件設備
      • 樂器
      • 耗材/試劑
    • 測試/實驗室（服務）
    • 分析與解釋

8. 組學研究服務市場——細分分析，按最終用途，2018-2030 年（百萬美元）

  • 定義和範圍
  • 組學研究服務市場：最終用途變化分析
    • 癌症
    • 製藥公司
      • 處方
      • 非處方藥（非處方藥）
    • 再生產
    • 其他遺傳病
    • 取證
      • 2018-2030 年法醫市場估計和預測（百萬美元）
    • 人口統計學
    • 皮膚護理
    • 營養
    • 維生素和補充劑
    • 家譜
      • 2018-2030 年家譜市場估計和預測（百萬美元）
    • 其他類
      • 其他類別市場估計和預測，2018-2030（百萬美元）

第九章區域業務分析

  • 定義和範圍
  • 2021 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場快照
  • SWOT 分析，按因素（政治和法律、經濟和技術）
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 馬雷
  • 2021-2030 年市場規模、預測和趨勢分析
  • 北美
    • 美國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 加拿大
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
  • 歐洲
    • 英國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 德國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 西班牙
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 法國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 意大利
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 俄羅斯
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 丹麥
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 瑞典
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 挪威
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
  • 亞太地區
    • 日本
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 中國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 印度
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 韓國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 泰國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 澳大利亞
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
  • 拉丁美洲
    • 巴西
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 墨西哥
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 阿根廷
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
  • 馬雷
    • 南非
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 沙特阿拉伯
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景
    • 科威特
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 最近的發展
      • 投資場景

第 10 章 競爭分析

  • 公司/競爭對手分類（主要創新者、市場領導者、初創企業）
  • 戰略框架
  • 市場參與的分類
  • 主要市場進入者的最新發展和影響分析
  • 公司定位分析
  • 代理商名單
    • 主要客戶
    • 上市公司
    • 民營企業
  • 案例分析
    • 案例研究：基於血液的 NGS 在非小細胞肺癌 (Nsclc) 治療決策中的應用
      • NGS對急性髓性白血病治療方案的影響
    • 案例研究：預測癌症治療反應
      • 挑戰：了解對免疫檢查點抑製劑治療的反應
      • 見解：代謝組學識別免疫檢查點抑製劑治療應答者的不同代謝物
      • 解決方案：與無反應者相比，免疫檢查點抑製劑治療反應者俱有不同的代謝組學特徵
      • 結果：代謝組學確定了治療反應的預測性生物標誌物
    • 案例研究：臨床試驗設計
      • 任務
      • 代謝酮洞察力
      • 解決方案
      • 結果
    • 案例研究：幽門螺桿菌如何形成
      • 任務
      • 方法
      • 結果
    • 案例研究：基因組診斷中 Cnv 和 Snv 的聯合分析
      • 分析
      • 結果：
      • 結論

第十一章公司簡介

  • 公司簡介
    • AGILENT TECHNOLOGIES, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • BEIJING GENOMICS INSTITUTE（BGI）
      • 公司簡介
      • Complete Genomics Inc.
      • 產品基準
      • 戰略舉措
    • Q2 SOLUTIONS
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • SPECTRUS
      • 公司簡介
      • 產品基準
    • FLOMICS BIOTECH
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • PHENOSWITCH BIOSCIENCE
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • QIAGEN
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • QUEST DIAGNOSTICS INCORPORATED
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • THERMO FISHER SCIENTIFIC, INC.
      • 公司簡介
      • Life Technologies Co., Ltd.
      • Affymetrix
      • Applied Biosystems
      • 財務績效
      • 產品基準
      • 戰略舉措
    • ILLUMINA, INC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-014-8

Omics Lab Services Market Growth & Trends:

The global omics lab services market size is expected to reach USD 194.04 billion by 2030, registering CAGR of 13.72% during the forecast period, according to a new report by Grand View Research, Inc. The development of the market is attributed to growing integration of the genomics data into clinical workflow and rising adoption of direct-to-consumer omics. Moreover, rising demand for early disease diagnostic test, technological advancements aided with increasing government funding is further propelling growth of the overall market.

Growing recognition of omics' potential in human disease management and other nonconventional applications has fueled the implementation of omics data. This, in turn, has increased competition among firms to introduce products and technologies by leveraging available genetic information, capitalizing on the ample growth avenues in the market. Advanced laboratory analytics also support the development of precision and personalized medicine, which has an influence beyond general patient care. Thorough progress has already been made in the field of oncology, and developments in omics and single-cell micro technology have greatly benefited progress toward upcoming patient-centered approach.

Moreover, the field of oncology has benefited most from omics research, and one newly developed use of NGS clinical tests is for the quantification of circulating tumor DNA (ctDNA) from plasma. Numerous NGS technologies, such as Cancer Personalized Profiling by deep Sequencing, may be used. High-throughput RNA sequencing developments have brought light the importance of transcriptomics in biological and clinical research. RNA sequencing using NGS technologies or microarrays are two ways to perform transcriptomics. Proteomics and metabolomics are two domains that have been significantly characterized by improvements in NMR and MS technologies.

Furthermore, key players operating in the market are focusing on incorporating omics technology in early diagnosis. For instance, in May 2021, Burning Rock Biotech Limited launched PRESCIENT, first pan cancer, multi omics early detection study in China. In March 2022, PrognomiQ invested USD 46.0 million in advancing development of multiomics for early detection of cancer. In September 2022, Bertis launched Proteomic based research of its new biomarkers for diagnosis of ovarian cancer. Moreover, in July 2022, Mission Bio, Inc. launched Tapestri platform for single cell multiomics-based MRD detection in blood cancers. These initiatives and research in the field of omics for the development of early diagnosis tools is further propelling the overall omics labs services market growth.

Omics Lab Services Market Report Highlights:

  • Epigenetic segment is expected to show fastest growth during the forecast period which can be attributed to the future potential offered by epigenetic analysis
  • Diagnostic labs segment held the largest market share in 2021 owing to the rising testing and availability of the wide range of resources for performing diagnostic tests
  • Hardware equipment segment dominated the omics lab services market in 2021 and is anticipated to show at fastest growth rate during the forecast period owing to Rapid technological advancements in genomics and transcriptomics through the development of hardware equipments
  • North America held the largest market share which can be attributed to the increasing adoption of genetic testing due to its high accuracy, sensitivity, and specificity

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Secondary Sources
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom-Up Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Research Assumptions
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Omics Lab Services Market Variables, Trends, and Scope

  • 3.1 Omics Lab Services Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
      • 3.1.1.1 Diagnostics Market
      • 3.1.1.2 Biotechnology Market
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing Integration Of Genomics Data Into Clinical Workflows
      • 3.3.1.1 More Targeted And Personalized Healthcare
      • 3.3.1.2 Growth Of Newborn Genetic Screening Programs
      • 3.3.1.3 Advancements In Noninvasive Cancer Screening
    • 3.3.2 Rising Adoption Of Direct-To-Consumer Omics
    • 3.3.3 Rising Demand For Early Disease Diagnostic Tests
    • 3.3.4 Technological Advancements
    • 3.3.5 Increasing Demand/ Adoption For Services
    • 3.3.6 Increasing Participation Of Different Companies
    • 3.3.7 Increasing Government Funding
  • 3.4 Market Restraint Analysis
    • 3.4.1 Lack Of Skilled Professionals
    • 3.4.2 Slow Implementation Of Omics Technology
  • 3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.6 Porter's Five Forces Analysis
  • 3.7 Regulatory Framework

Chapter 4 Omics Lab Services Market - Segment Analysis, By Service, 2018 - 2030 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Omics Lab Services Market: Service Movement Analysis
    • 4.2.1 Genomics
      • 4.2.1.1 Genomics Lab Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.2 Proteomics
      • 4.2.2.1 Proteomics Lab Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.3 Transcriptomics
      • 4.2.3.1 Transcriptome In-Vivo Analysis (Tiva)
      • 4.2.3.2 Ihc
      • 4.2.3.3 Microscopy-Based Rns Imaging Techniques
      • 4.2.3.4 Transcriptomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.4 Metabolomics
      • 4.2.4.1 Metabolomics Lab Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.5 Epigenetics
      • 4.2.5.1 Epigenetics Market Estmates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Omics Lab Services Market - Segment Analysis, By Business, 2018 - 2030 (USD Million)

  • 5.1 Omics Lab Services Market: Business Movement Analysis
    • 5.1.1 Hospitals
      • 5.1.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.2 Research Institutes
      • 5.1.2.1 Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.3 Diagnostic Labs
      • 5.1.3.1 Diagnostic Labs Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Omics Lab Services Market - Segment Analysis, By Frequency Of Service, 2018 - 2030 (USD Million)

  • 6.1 Definition And Scope
  • 6.2 Omics Lab Services Market: Frequency Of Service Movement Analysis
    • 6.2.1 One-Off
      • 6.2.1.1 One-Off Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Repeat
      • 6.2.2.1 Repeat Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.3 Continuous
      • 6.2.3.1 Continuous Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Omics Lab Services Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 7.1 Definition And Scope
  • 7.2 Omics Lab Services Market: Product Movement Analysis
    • 7.2.1 Hardware Equipment
      • 7.2.1.1 Instruments
      • 7.2.1.2 Consumables/Reagents
      • 7.2.1.3 Hardware Equipment Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 Testing/Lab (Services)
      • 7.2.2.1 Testing/Lab Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.3 Analytics/Interpretation
      • 7.2.3.1 Analytics/Interpretation Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Omics Lab Services Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 8.1 Definition And Scope
  • 8.2 Omics Lab Services Market: End-Use Movement Analysis
    • 8.2.1 Cancer
      • 8.2.1.1 Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 Pharmaco
      • 8.2.2.1 Pharmaco Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.2.2.2 Prescription
      • 8.2.2.2.1 Prescription Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.2.2.3 Non-Prescription (Otc)
      • 8.2.2.3.1 Non-Prescription Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Reproductive
      • 8.2.3.1 Reproductive Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.4 Other Genetic Disease
      • 8.2.4.1 Other Genetic Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.5 Forensics
      • 8.2.5.1 Forensics Market Estmates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.6 Population Studies
      • 8.2.6.1 Population Studies Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.7 Skincare
      • 8.2.7.1 Skincare Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.8 Nutrition
      • 8.2.8.1 Nutrition Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.9 Vitamins And Supplements
      • 8.2.9.1 Vitamins And Supplements Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.10 Genealogy
      • 8.2.10.1 Genealogy Market Estmates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.11 Other Categories
      • 8.2.11.1 Other Categories Market Estmates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 Definition & Scope
  • 9.2 Regional Market Share Analysis, 2021&2030
  • 9.3 Regional Market Dashboard
  • 9.4 Regional Market Snapshot
  • 9.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 9.5.1 North America
    • 9.5.2 Europe
    • 9.5.3 Asia Pacific
    • 9.5.4 Latin America
    • 9.5.5 Mea
  • 9.6 Market Size, & Forecasts, Trend Analysis, 2021 To 2030
  • 9.7 North America
    • 9.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Billion)
    • 9.7.2 U.S.
      • 9.7.2.1 U.S. Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.7.2.2 Key Country Dynamics
      • 9.7.2.3 Regulatory Framework
      • 9.7.2.4 Competitive Scenario
      • 9.7.2.5 Recent Developments
      • 9.7.2.6 Investments Scenario
    • 9.7.3 Canada
      • 9.7.3.1 Canada Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.7.3.2 Key Country Dynamics
      • 9.7.3.3 Regulatory Framework
      • 9.7.3.4 Competitive Scenario
      • 9.7.3.5 Recent Developments
      • 9.7.3.6 Investments Scenario
  • 9.8 Europe
    • 9.8.1 Urope Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.8.2 Uk
      • 9.8.2.1 Uk Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.2.2 Key Country Dynamics
      • 9.8.2.3 Regulatory Framework
      • 9.8.2.4 Competitive Scenario
      • 9.8.2.5 Recent Developments
      • 9.8.2.6 Investments Scenario
    • 9.8.3 Germany
      • 9.8.3.1 Germany Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.3.2 Key Country Dynamics
      • 9.8.3.3 Regulatory Framework
      • 9.8.3.4 Competitive Scenario
      • 9.8.3.5 Recent Developments
      • 9.8.3.6 Investments Scenario
    • 9.8.4 Spain
      • 9.8.4.1 Spain Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.4.2 Key Country Dynamics
      • 9.8.4.3 Regulatory Framework
      • 9.8.4.4 Competitive Scenario
      • 9.8.4.5 Recent Developments
      • 9.8.4.6 Investments Scenario
    • 9.8.5 France
      • 9.8.5.1 France Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.5.2 Key Country Dynamics
      • 9.8.5.3 Regulatory Framework
      • 9.8.5.4 Competitive Scenario
      • 9.8.5.5 Recent Developments
      • 9.8.5.6 Investments Scenario
    • 9.8.6 Italy
      • 9.8.6.1 Italy Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.6.2 Key Country Dynamics
      • 9.8.6.3 Regulatory Framework
      • 9.8.6.4 Competitive Scenario
      • 9.8.6.5 Recent Developments
      • 9.8.6.6 Investments Scenario
    • 9.8.7 Russia
      • 9.8.7.1 Russia Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.7.2 Regulatory Framework
      • 9.8.7.3 Competitive Scenario
      • 9.8.7.4 Recent Developments
      • 9.8.7.5 Investments Scenario
    • 9.8.8 Denmark
      • 9.8.8.1 Denmarkomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.8.2 Key Country Dynamics
      • 9.8.8.3 Regulatory Framework
      • 9.8.8.4 Competitive Scenario
      • 9.8.8.5 Recent Developments
      • 9.8.8.6 Investments Scenario
    • 9.8.9 Sweden
      • 9.8.9.1 Sweden Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.9.2 Key Country Dynamics
      • 9.8.9.3 Regulatory Framework
      • 9.8.9.4 Competitive Scenario
      • 9.8.9.5 Recent Developments
      • 9.8.9.6 Investments Scenario
    • 9.8.10 Norway
      • 9.8.10.1 Norway Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.10.2 Key Country Dynamics
      • 9.8.10.3 Regulatory Framework
      • 9.8.10.4 Competitive Scenario
      • 9.8.10.5 Recent Developments
      • 9.8.10.6 Investments Scenario
  • 9.9 Asia Pacific
    • 9.9.1 Asia-Pacific Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.9.2 Japan
      • 9.9.2.1 Japan Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.2.2 Key Country Dynamics
      • 9.9.2.3 Regulatory Framework
      • 9.9.2.4 Competitive Scenario
      • 9.9.2.5 Recent Developments
      • 9.9.2.6 Investments Scenario
    • 9.9.3 China
      • 9.9.3.1 Chinaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.3.2 Key Country Dynamics
      • 9.9.3.3 Regulatory Framework
      • 9.9.3.4 Competitive Scenario
      • 9.9.3.5 Recent Developments
      • 9.9.3.6 Investments Scenario
    • 9.9.4 India
      • 9.9.4.1 Indiaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.4.2 Key Country Dynamics
      • 9.9.4.3 Regulatory Framework
      • 9.9.4.4 Competitive Scenario
      • 9.9.4.5 Recent Developments
      • 9.9.4.6 Investments Scenario
    • 9.9.5 South Korea
      • 9.9.5.1 South Koreaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.5.2 Key Country Dynamics
      • 9.9.5.3 Regulatory Framework
      • 9.9.5.4 Competitive Scenario
      • 9.9.5.5 Recent Developments
      • 9.9.5.6 Investments Scenario
    • 9.9.6 Thailand
      • 9.9.6.1 Thailandomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.6.2 Key Country Dynamics
      • 9.9.6.3 Regulatory Framework
      • 9.9.6.4 Competitive Scenario
      • 9.9.6.5 Recent Developments
      • 9.9.6.6 Investments Scenario
    • 9.9.7 Australia
      • 9.9.7.1 Australiaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.7.2 Key Country Dynamics
      • 9.9.7.3 Regulatory Framework
      • 9.9.7.4 Competitive Scenario
      • 9.9.7.5 Recent Developments
      • 9.9.7.6 Investments Scenario
  • 9.10 Latin America
    • 9.10.1 Latin America Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.10.2 Brazil
      • 9.10.2.1 Brazilomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.10.2.2 Key Country Dynamics
      • 9.10.2.3 Regulatory Framework
      • 9.10.2.4 Competitive Scenario
      • 9.10.2.5 Recent Developments
      • 9.10.2.6 Investments Scenario
    • 9.10.3 Mexico
      • 9.10.3.1 Mexicoomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.10.3.2 Key Country Dynamics
      • 9.10.3.3 Regulatory Framework
      • 9.10.3.4 Competitive Scenario
      • 9.10.3.5 Recent Developments
      • 9.10.3.6 Investments Scenario
    • 9.10.4 Argentina
      • 9.10.4.1 Argentinaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.10.4.2 Key Country Dynamics
      • 9.10.4.3 Regulatory Framework
      • 9.10.4.4 Competitive Scenario
      • 9.10.4.5 Recent Developments
      • 9.10.4.6 Investments Scenario
  • 9.11 Mea
    • 9.11.1 Mea Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.11.2 South Africa
      • 9.11.2.1 South Africaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.2.2 Key Country Dynamics
      • 9.11.2.3 Regulatory Framework
      • 9.11.2.4 Competitive Scenario
      • 9.11.2.5 Recent Developments
      • 9.11.2.6 Investments Scenario
    • 9.11.3 Saudi Arabia
      • 9.11.3.1 Saudi Arabiaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.3.2 Key Country Dynamics
      • 9.11.3.3 Regulatory Framework
      • 9.11.3.4 Competitive Scenario
      • 9.11.3.5 Recent Developments
      • 9.11.3.6 Investments Scenario
    • 9.11.4 Uae
      • 9.11.4.1 Uaeomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.4.2 Key Country Dynamics
      • 9.11.4.3 Regulatory Framework
      • 9.11.4.4 Competitive Scenario
      • 9.11.4.5 Recent Developments
      • 9.11.4.6 Investments Scenario
    • 9.11.5 Kuwait
      • 9.11.5.1 Kuwaitomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.5.2 Key Country Dynamics
      • 9.11.5.3 Regulatory Framework
      • 9.11.5.4 Competitive Scenario
      • 9.11.5.5 Recent Developments
      • 9.11.5.6 Investments Scenario

Chapter 10 Competitive Analysis

  • 10.1 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 10.2 Strategy Framework
  • 10.3 Market Participation Categorization
  • 10.4 Recent Developments & Impact Analysis, By Key Market Participants
  • 10.5 Company Position Analysis
  • 10.6 List Of Distributors
    • 10.6.1 Key Customers
    • 10.6.2 Public Companies
    • 10.6.3 Private Companies
  • 10.7 Case Studies
    • 10.7.1 Case Study: Blood-Based Ngs In Treatment Decision-Making For Non-Small Cell Lung Cancer (Nsclc)
      • 10.7.1.1 Impact Of Ngs On Treatment Selection In Acute Myeloid Leukemia
    • 10.7.2 Case Study: Cancer Treatment Response Prediction
      • 10.7.2.1 The Challenge: Understanding Immune Checkpoint Inhibitor Therapy Response
      • 10.7.2.2 Insight: Metabolomics Identifies Differential Metabolites In Responders To Immune Checkpoint Inhibitor Therapy
      • 10.7.2.3 The Solution: Immune Checkpoint Inhibitor Therapy Responders Have Different Metabolomic Profiles Compared To Non-Responders
      • 10.7.2.4 The Result: Metabolomics Identifies Predictive Biomarkers For Treatment Response
    • 10.7.3 Case Study: Clinical Trial Design
      • 10.7.3.1 The Challenge
      • 10.7.3.2 Metabolon Insight
      • 10.7.3.3 The Solution
      • 10.7.3.4 The Outcome
    • 10.7.4 Case Study: How H. Pylori Get Its Shape
      • 10.7.4.1 The Challenge
      • 10.7.4.2 The Approach
      • 10.7.4.3 The Outcome
    • 10.7.5 Case Study: Combined Analysis Of Cnvs And Snvs In Genomic Diagnostics
      • 10.7.5.1 Analysis
      • 10.7.5.2 Result:
      • 10.7.5.3 Conclusion

Chapter 11 Company Profiles

  • 11.1 Company Profiles
    • 11.1.1 AGILENT TECHNOLOGIES, INC.
      • 11.1.1.1 Company Overview
      • 11.1.1.2 Financial Performance
      • 11.1.1.3 Product Benchmarking
      • 11.1.1.4 Strategic Initiatives
    • 11.1.2 BEIJING GENOMICS INSTITUTE (BGI)
      • 11.1.2.1 Company Overview
      • 11.1.2.1.1Complete Genomics Incorporated
      • 11.1.2.2 Product Benchmarking
      • 11.1.2.3 Strategic Initiatives
    • 11.1.3 Q2 SOLUTIONS
      • 11.1.3.1 Company Overview
      • 11.1.3.2 Product Benchmarking
      • 11.1.3.3 Strategic Initiatives
    • 11.1.4 SPECTRUS
      • 11.1.4.1 Company Overview
      • 11.1.4.2 Product Benchmarking
    • 11.1.5 FLOMICS BIOTECH
      • 11.1.5.1 Company Overview
      • 11.1.5.2 Product Benchmarking
      • 11.1.5.3 Strategic Initiatives
    • 11.1.6 PHENOSWITCH BIOSCIENCE
      • 11.1.6.1 Company Overview
      • 11.1.6.2 Product Benchmarking
      • 11.1.6.3 Strategic Initiatives
    • 11.1.7 QIAGEN
      • 11.1.7.1 Company Overview
      • 11.1.7.1 Financial Performance
      • 11.1.7.2 Product Benchmarking
      • 11.1.7.3 Strategic Initiatives
    • 11.1.8 QUEST DIAGNOSTICS INCORPORATED
      • 11.1.8.1 Company Overview
      • 11.1.8.2 Financial Performance
      • 11.1.8.3 Product Benchmarking
      • 11.1.8.4 Strategic Initiatives
    • 11.1.9 THERMO FISHER SCIENTIFIC, INC.
      • 11.1.9.1 Company Overview
      • 11.1.9.1.1 Life Technologies Corp.
      • 11.1.9.1.2 Affymetrix
      • 11.1.9.1.3 Applied Biosystems
      • 11.1.9.2 Financial Performance
      • 11.1.9.3 Product Benchmarking
      • 11.1.9.4 Strategic Initiatives
    • 11.1.10 ILLUMINA, INC
      • 11.1.10.1 Company Overview
      • 11.1.10.2 Financial Performance
      • 11.1.10.3 Product Benchmarking
      • 11.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Omics Lab Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 6 Global Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 7 Global Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 8 Global Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 Global Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10 North America Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 12 North America Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 13 North America Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 14 North America Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 North America Omics Lab Services Market, By End-use, 2018 - 2030 (USD Million)
  • Table 16 U.S. Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 17 U.S. Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 18 U.S. Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 19 U.S. Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 U.S. Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Canada Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 22 Canada Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 23 Canada Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 24 Canada Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Canada Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Europe Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 27 Europe Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 28 Europe Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 29 Europe Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 30 Europe Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Europe Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 UK Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 33 UK Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 34 UK Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 35 UK Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 UK Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Germany Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 38 Germany Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 39 Germany Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 40 Germany Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 Germany Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42 France Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 43 France Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 44 France Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 45 France Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 France Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Spain Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 48 Spain Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 49 Spain Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 50 Spain Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Spain Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Italy Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 53 Italy Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 54 Italy Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 55 Italy Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Italy Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Denmark Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 58 Denmark Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 59 Denmark Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 60 Denmark Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 Denmark Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Sweden Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 63 Sweden Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 64 Sweden Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 65 Sweden Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 66 Sweden Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67 Norway Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 68 Norway Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 69 Norway Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 70 Norway Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Norway Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Japan Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 79 Japan Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 80 Japan Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 81 Japan Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 Japan Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 83 China Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 84 China Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 85 China Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 86 China Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 China Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Australia Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 89 Australia Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 90 Australia Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 91 Australia Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 Australia Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 93 Thailand Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 94 Thailand Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 95 Thailand Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 96 Thailand Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Thailand Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 98 India Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 99 India Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 100 India Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 101 India Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 102 India Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 103 South Korea Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 104 South Korea Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 105 South Korea Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 106 South Korea Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 107 South Korea Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 108 Latin America Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 109 Latin America Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 110 Latin America Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 111 Latin America Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 112 Latin America Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 113 Latin America Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 114 Mexico Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 115 Mexico Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 116 Mexico Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 117 Mexico Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 Mexico Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 119 Brazil Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 120 Brazil Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 121 Brazil Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 122 Brazil Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 123 Brazil Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 124 Argentina Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 125 Argentina Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 126 Argentina Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 127 Argentina Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 128 Argentina Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 129 MEA Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 130 MEA Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 131 MEA Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 132 MEA Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 133 MEA Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 134 MEA Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 135 South Africa Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 136 South Africa Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 137 South Africa Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 138 South Africa Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 139 South Africa Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 140 South Africa Omics Lab Services Market, By End-use, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 145 Saudi Arabia Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 146 Saudi Arabia Omics Lab Services Market, By End-use, 2018 - 2030 (USD Million)
  • Table 147 UAE Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 148 UAE Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 149 UAE Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 150 UAE Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 151 UAE Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 154 Kuwait Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 155 Kuwait Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 156 Kuwait Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Omics lab services market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot (Service, Business)
  • Fig. 11 Segment snapshot (Frequency of Service, Product)
  • Fig. 12 Segment snapshot (End-Use)
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Omics lab services market driver impact
  • Fig. 16 Categories of tests offered by DTC companies
  • Fig. 17 Benefits of earlier detection of cancer
  • Fig. 18 Use of cancer biomarkers in cancer management
  • Fig. 19 Adoption of Omics services
  • Fig. 20 Omics lab services market restraint impact
  • Fig. 21 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Omics lab services market: Service outlook and key takeaways
  • Fig. 24 Omics lab services market: Service movement analysis
  • Fig. 25 Genomics Players
  • Fig. 26 Genomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Proteomics Players
  • Fig. 28 Proteomics Landscape
  • Fig. 29 Proteomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Transcriptomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Metabolomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Epigenetics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Omics lab services market : Business outlook and key takeaways
  • Fig. 34 Omics lab services market: Business movement analysis
  • Fig. 35 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Omics lab services market : Frequency of service outlook and key takeaways
  • Fig. 39 Omics lab services market: Frequency of service movement analysis
  • Fig. 40 One-off market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Repeat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Continuous market estimates and forecast,, 2018 - 2030 (USD Million)
  • Fig. 43 Omics lab services market : Product outlook and key takeaways
  • Fig. 44 Omics lab services market: Product movement analysis
  • Fig. 45 Hardware equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Testing/Lab market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Analytics/Interpretation market estimates and forecast,, 2018 - 2030 (USD Million)
  • Fig. 48 Omics lab services market: End-use outlook and key takeaways
  • Fig. 49 Omics lab services market: End-use movement analysis
  • Fig. 50 Multi-omics approach in cancer screening
  • Fig. 51 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pharmaco market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Non-Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Reproductive market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Other genetic disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Relationship between omics and phenotypes
  • Fig. 58 Forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Population studies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Skincare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Nutrition market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Vitamins and supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Genealogy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Other categories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Regional marketplace: Key takeaway
  • Fig. 66 Omics lab services market: Regional movement analysis
  • Fig. 67 Global omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 68 North America omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 69 Europe omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East & Africa omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 73 Australia omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 74 Singapore omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 75 GCC omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 77 Rest of GCC omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 78 UK omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 79 Thailand omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 80 ASEAN countries omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 81 Ansoff Matrix
  • Fig. 82 Strategy mapping
  • Fig. 83 Companies operating in the market
  • Fig. 84 Potentially actionable genes considered during the study
  • Fig. 85 Study results
  • Fig. 86 Workflow overview of tiered analysis approach developed at UMC Utrecht and implemented with Alissa Interpret
  • Fig. 87 Results of the tiered approach